FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Indegene IPO.
October 24, 2024 8:31:00 AM
You can call it the Hyundai effect, but the IPO collections in calendar 2024 have already crossed ?1.1 trillion!
Published by : India InfolineOctober 11, 2024 9:48:00 AM
Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest biotechs to list on the Nasdaq. Upstream had previously expected to ...
Published by : FierceBiotechOctober 15, 2024 8:30:00 PM
Ceribell rang in a $180.3 million IPO last week, with its public debut on the Nasdaq coming in well above its first pricing goal of about $101 million and its stock price trading up about 47% ...
Published by : FierceBiotechOctober 29, 2024 1:05:00 PM
And it's been a long downward trend since then. If you had held on to your shares since the IPO date in late 1999, you would have lost nearly 99% of your initial capital. The company went through ...
Published by : The Motley FoolOctober 7, 2024 2:37:00 PM
The release of five and six months lock-in include Bharti Hexacom, JNK India, Indegene, TBO TEK, Aadhar Housing Finance, Go Digit General Insurance, Awfis Space Solutions, Kronox Lab Sciences ...
Published by : Business LineOctober 6, 2024 6:30:00 PM
One such start-up, Cerebras, just filed a prospectus ahead of an impending initial public offering (IPO). After reading, I think Cerebras is a name every Nvidia investor should monitor closely.
Published by : NasdaqOctober 7, 2024 7:28:00 PM
Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as soon as 2024, according to people with knowledge of the matter.
Published by : Bloomberg L.P.October 28, 2024 5:09:00 PM
Swiggy plans a Rs 11,327 crore IPO on Nov 6, aiming for $11.3 billion valuation, adjusted from up to $13 billion due to market conditions. Prosus, Accel, and Elevation Capital will sell part of ...
Published by : IndiatimesOctober 19, 2024 11:04:00 PM
But the filing to go public reveals that Pony’s board of directors recently slashed the minimum valuation for its IPO down to $4 billion. Pony also dropped its minimum target for what it wants ...
Published by : TechCrunchNovember 1, 2024 4:30:00 AM
PETALING JAYA: The public portion of electronics manufacturing services provider Nationgate Holdings Bhd ’s initial public offering (IPO) has been oversubscribed 16.49 times.The ACE Market-bound ...
Published by : The StarOctober 9, 2024 1:04:00 AM
The Barcelona-based company was planning to sell around 29% of its capital on the market or 31.7%, including the over-allotment option, in an IPO that was expected to be worth approximately up to ...
Published by : ReutersThe IPO Shares of Indegene Limited IPO are proposed to list on Monday, May 13, 2024 at BSE, NSE. The public issue of Indegene IPO was opened on May 6, 2024 and closed for subscription on May 8, 2024. Indegene IPO Listing Date and Information:
Listing Date | Monday, May 13, 2024 |
BSE Script Code | 544172 |
NSE Symbol | INDGN |
Listing In | B Group of Securities |
ISIN | INE065X01017 |
Issue Price | ₹452 Per Equity Share |
Face Value | ₹2 Per Equity Share |
The allotment status of Indegene Limited IPO is now available online. The public issue of Indegene IPO was open on May 6, 2024 and closed for subscription on May 8, 2024. The equity shares of the company to be list at BSE, NSE
.
Indegene Limited is entering in the capital market with an IPO of 40,746,891 Equity Shares of Rs 2 aggregating up to Rs 1,841.76 Crore. The price for the issue has been set at Rs 430 - Rs 452 Per Equity Share.
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
The issue opens on May 6, 2024 and closes for subscription on May 8, 2024. The equity shares of the company to be list at BSE, NSE.
The issue of Indegene Limited opens on May 6, 2024 and closes for subscription on May 8, 2024. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 430 - Rs 452 Per Equity Share.
The Indegene IPO is proposed to open on May 6, 2024. The IPO application ends on May 8, 2024.
Retail investors can apply in the retail or non-institutional investor category from May 6, 2024 to May 8, 2024. The Indegene IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Indegene IPO will open for subscription on May 6, 2024. The public issue will close on May 8, 2024.
Useful Articles
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|